About
The models provided by this website have been
published in peer reviewed scientific journals, and
these pages can be considered as a supplement. For
deatails of the model development and validation,
readers are referred to these articles:
- for the IBR model:
Erik van Werkhoven, Guus Hart, Harm van Tinteren, et al.
Nomogram to predict ipsilateral breast relapse based on pathology
review from the EORTC 22881–10882 boost versus no boost trial.
Radiotherapy and Oncology, 100 (2011),
pp. 101–107
(free access);
- for the fibrosis model:
Sandra Collette, Laurence Collette, Tom Budiharto, et al.
Predictors of the risk of fibrosis at 10 years after
breast conserving therapy for early breast cancer – A
study based on the EORTC trial 22881 – 10882
‘boost versus no boost’.
European Journal of Cancer, 44
(2008), pp. 2587–2599.
Links
Acknowledgements
This website is hosted by
The Netherlands Cancer Institute / Antoni van
Leeuwenhoek Hospital (NKI/AvL).
The fibrosis model was kindly provided by the
EORTC.
Contact
Contact the
author/maintainer:
.